US2004167349A1PendingUtilityA1
Novel process for preparing rac-bicalutamide and its intermediates
Priority: Jun 13, 2001Filed: Mar 1, 2004Published: Aug 26, 2004
Est. expiryJun 13, 2021(expired)· nominal 20-yr term from priority
C07C 255/58C07C 315/04C07D 301/14C07C 317/14C07C 319/14
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a new process for the synthesis of racemic and optically active bicalutamide starting from ethyl pyruvate and methyl methacrylate. The present invention discloses processes of preparing bicalutamide intermediates including ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionate, 1,2-epoxy-2-methyl propionate and 2-hydrox-2-methyl-3-(4-fluorophenylthio) propionic acid. The present invention further discloses micronized rac-bicalutamide and the preparation thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A rac-bicalutamide intermediate having the chemical strcuture of [X], wherein [X] is a stable organo lithium salt of 4-fluorophenyl methyl sulfone.
2 . A process of preparing a rac-bicalutamide intermediate having the chemical structure of [X], comprising the steps of:
a) dissovling 4-fluorophenyl methyl sulfone in an organic solvent; and b) adding butyl lithium to the solution, wherein butyl lithium reacts with 4-fluorophenyl methyl sulfone to form [X].
3 . The process according to claim 2 , wherein the organic solvent is selected from the group consisting of tetrahydrofuran and diethyl ether.
4 . The process according to claim 2 , wherein the reaction between butyl lithium with 4-fluorophenyl methyl sulfone occurs in the presence of an anion stabilizer.
5 . The process according to claim 4 , wherein the anion stabilizer is 1,4 diazabicylo[2.2.2]octane.
6 . The process according to claim 2 , wherein the reaction between butyl lithium with 4-fluorophenyl methyl sulfone occurs in a temperature range between about −40° C. to about +10° C.
7 . The process according to claim 2 , wherein the reaction between butyl lithium with 4-fluorophenyl methyl sulfone occurs in a temperature range between about −2° C. and about +2° C.
8 . A process of preparing ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionate, comprises the steps of:
a) preparing a mixture of 4-fluorophenyl methyl sulfone and butyl lithium in an organic solvent; b) adding ethyl pyruvate; and c) recovering ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionate.
9 . The process according to claim 8 , wherein the organic solvent is tetrahydrofuran.
10 . The process according to claim 8 , wherein the ethyl pyruvate is added to the mixture at a temperature of about −65° C.
11 . The process according to claim 8 , wherein the recovering step comprises evaporating the mixture containing ethyl pyruvate.
12 . The process according to claim 8 , wherein the recovering step further comprises separating the ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionate.
13 . A rac-bicalutamide intermediate having the chemical strcuture of [Y], wherein [Y] is a stable organo lithium salt of 5-amino-2-cyano-benzotrifluoride.
14 . A process of preparing a rac-bicalutamide intermediate having the chemical structure of [Y], comprising the steps of:
a) dissovling 5-amino-2-cyano-benzotriflouride in an organic solvent; and b) adding butyl lithium to the solution, wherein butyl lithium reacts with 5-amino-2-cyano-benzotrifloride to form [Y].
15 . The process according to claim 14 , wherein the organic solvent is selected from the group consisting of tetrahydrofuran and diethyl ether.
16 . The process according to claim 14 , wherein the reaction between butyl lithium with 5-amino-2-cyano-benzotrifloride occurs in the presence of an anion stabilizer.
17 . The process according to claim 16 , wherein the anion stabilizer is 1,4 diazabicylo[2.2.2]octane.
18 . The process according to claim 14 , wherein the reaction between butyl lithium with 5-amino-2-cyano-benzotrifloride occurs in a temperature range between about −40° C. to about +10° C.
19 . The process according to claim 14 , wherein the reaction between butyl lithium with 5-amino-2-cyano-benzotrifloride occurs in a temperature range between about −2° C. and about +2° C.
20 . A process of preparing rac-bicalutamide, comprising the steps of:
a) preparing a mixture of 5-amino-2-cyano-benzotrifluoride and butyl lithium in an organic solvent; b) adding ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid to the mixture; and c) recovering rac-bicalutamide.
21 . The process according to claim 20 , wherein the organic solvent is selected from the group consisting of tetrahydrofuran and diethyl ether.
22 . The process according to claim 20 , wherein the ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid is added to the mixture at a temperature of about −65° C.
23 . The process according to claim 20 , wherein recovering step comprises evaporating the mixture containing ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid.
24 . The process according to claim 20 , wherein the recovering step further comprises separating the ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid.
25 . The process according to claim 20 , wherein the rac-bicalutamide is an R-isomer.
26 . The process according to claim 20 , wherein the rac-bicalutamide is an S-isomer.
27 . A process of preparing methyl 1,2-epoxy-2-methyl propionate, comprising the steps of:
a) dissolving oxone in a basic solution; b) adding methyl methacrylate to the oxone solution; c) adding an acid to the oxone solution to form methyl 1,2-epoxy-2-methyl propionate; and d) recovering methyl 1,2-epoxy-2-methyl propionate.
28 . The process according to claim 27 , wherein the basic solution is selected from the group consisting of potassium hydroxide and sodium hydroxide.
29 . The process according to claim 28 , wherein the potassium hydroxide has a concentration of 10 M.
30 . The process according to claim 27 , wherein the oxone is 50% KHSO 5 .
31 . The process according to claim 27 , wherein the methyl methacrylate is added in methanol.
32 . The process according to claim 27 , wherein the oxone solution containing methyl methacrylate is maintained at about pH 6.
33 . The process according to claim 27 , wherein the acid is selected from the group consisting of hydrochloric acid, nitric acid and phosphoric acid.
34 . The process according to claim 33 , wherein the hydrochloric acid has a concentration of about 0.05 N to about 5 N.
35 . A process of preparing 2-hydroxy-2-methyl-3-(4-fluorophenylthio) propionic acid, comprising the steps of:
a) preparing a solution of 4-fluorothiophenol in methanol; b) adding methyl-1,2-epoxy-2-methyl propionate to form a mixture; c) adding ethyl acetate to the mixture; and d) recovering 2-hydroxy-2-methyl-3-(4-fluorophenylthio) propionic acid.
36 . The process according to claim 35 , wherein the preparation of 4-fluorothiophenol solution is performed by adding a basic solution under N 2 flow.
37 . The process according to claim 36 , wherien the basic solution is selected from the group consisting of sodium hydroxide and potassium hydroxide.
38 . The process according to claim 37 , wherein the sodium hydroxide has a concentration of 2 N.
39 . The process according to claim 35 , wherein the mixture is formed by stirring.
40 . The process according to claim 39 , wherein the stirring is performed at room temperature for 90 minutes.
41 . The process according to claim 35 , wherein the recovering step is extraction.
42 . The process according to claim 41 , wherein the extraction is achieved by chloroform.
43 . The process according to claim 35 , wherein the recovering step further involves solidifying 2-hydrox-2-methyl-3-(4-fluorophenylthio) propionic acid.
44 . A micronized rac-bicalutamide, wherein the micronized rac-bicalutamide has a mean particle diameter of less than about 200 μm.
45 . A micronized rac-bicalutamide, wherien the micronized rac-bicalutamide has a mean particle diameter of less than about 100 μm.
46 . A micronized rac-bicalutamide, wherein the micronized rac-bicalutamide has a mean particle diameter of less than 10 μm.
47 . A micronized rac-bicalutamide, wherein the micronized rac-bicalutamide has a mean particle diameter between about 200 μm to about 10 μm.
48 . A pharmaceutical composition of rac-bicalutamide comprising a micronized rac-bicalutamide and a pharmaceutically acceptable salt.
49 . The pharmaceutical composition of rac-bicalutamide wherein the micronized rac-bicalutamide has a mean particle diameter between about 200 μm to about 10 μm.Join the waitlist — get patent alerts
Track US2004167349A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.